Samuel J. R. A. Chawner

Samuel J. R. A. Chawner

Auto-generated profile, based on publicly available information

Samuel J. R. A. Chawner

Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences Cardiff University Cardiff UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DDDebra D’angelo
Debra D’angelo
SLSébastien Lebon
Sébastien Lebon
QCQixuan Chen
Qixuan Chen
SMSandra Martin-Brevet
Sandra Martin-Brevet
LSLeeAnne Green Snyder
LeeAnne Green Snyder
WCWendy K. Chung
Wendy K. Chung
The 600-kilobase (kb) break points 4 and 5 (BP4-BP5) 16p11.2 deletion and duplications (chr16; 29.6-30.2 megabase) are among the most frequent genetic causes of autism spectrum disorder (ASD), schizophrenia, and other neurodevelopmental disorders.1-5 These reciprocal copy number variants (CNVs) are associated with mirror phenotypes of obesity and being underweight and with increased and decreased global and regional brain volumes in deletion and duplication carriers, respectively.6-8 Previous studies5,9 have demonstrated that ASD is diagnosed in approximately 18% of deletion carriers and that this CNV affects global cognition by shifting the IQ approximately 2 SDs without altering the variance. To our knowledge, such studies have not been conducted for the reciprocal duplication. Akin to duplications of other genomic regions, case series10-18 have reported variable expressivity and suggested incomplete penetrance; however, incomplete penetrance was recently ruled out after recalling carriers identified in unselected populations.19 This phenotypic variability and the limited available data underscore the need to systematically characterize the clinical impact of the duplication with standardized assessments in large numbers of carriers.

16 January 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MNMaria Niarchou
Maria Niarchou
SCSamuel J. R. A. Chawner
Samuel J. R. A. Chawner
JDJoanne L. Doherty
Joanne L. Doherty
AMAnne M. Maillard
Anne M. Maillard
SJSébastien Jacquemont
Sébastien Jacquemont
Marianne van den BreeMarianne van den Bree
Marianne van den Bree
Deletion and duplication of 16p11.2 (BP4–BP5) have been associated with an increased risk of intellectual disability and psychiatric disorder. This is the first study to compare the frequency of a broad spectrum of psychiatric disorders in children with 16p11.2 deletion and duplication. We aimed to evaluate (1) the nature and prevalence of psychopathology associated with copy number variation (CNV) in children with 16p11.2 by comparing deletion and duplication carriers with family controls; (2) whether deletion and duplication carriers differ in frequency of psychopathology. 217 deletion carriers, 77 deletion family controls, 114 duplication carriers, and 32 duplication family controls participated in the study. Measures included standardized research diagnostic instruments. Deletion carriers had a higher frequency of any psychiatric disorder (OR = 8.9, p < 0.001), attention deficit hyperactivity disorder (ADHD) (OR = 4.0, p = 0.01), and autism spectrum disorder (ASD) (OR = 39.9, p = 0.01) than controls. Duplication carriers had a higher frequency of any psychiatric diagnosis (OR = 5.3, p = 0.01) and ADHD (OR = 7.0, p = 0.02) than controls. The prevalence of ASD in child carriers of deletions and duplications was similar (22% versus 26%). Comparison of the two CNV groups indicated a higher frequency of ADHD in children with the duplication than deletion (OR = 2.7, p = 0.04) as well as a higher frequency of overall psychiatric disorders (OR = 2.8, p = 0.02) and psychotic symptoms (OR = 4.7, p = 0.02). However, no differences between deletion and duplications carriers in the prevalence of ASD were found. Both deletion and duplication are associated with an increased risk of psychiatric disorder, supporting the importance of early recognition, diagnosis, and intervention in these groups.

1 June 2019 in The Lancet Psychiatry
Verified
Journal Article
Closed access
SCSamuel J R A Chawner
Samuel J R A Chawner
MOMichael J Owen
Michael J Owen
PHPeter Holmans
Peter Holmans
FRF Lucy Raymond
F Lucy Raymond
DSDavid Skuse
David Skuse
Marianne van den BreeMarianne van den Bree
Marianne van den Bree

1 March 2022 in American Journal of Psychiatry
Verified
Journal Article
Closed access
SJSébastien Jacquemont
Sébastien Jacquemont
GHGuillaume Huguet
Guillaume Huguet
MKMarieke Klein
Marieke Klein
SCSamuel J.R.A. Chawner
Samuel J.R.A. Chawner
KDKirsten A. Donald
Kirsten A. Donald
TNthe Genes to Mental Health Network
the Genes to Mental Health Network

3 February 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SMSinead Morrison
Sinead Morrison
SCSamuel J. R. A. Chawner
Samuel J. R. A. Chawner
TATherese A. M. J. van Amelsvoort
Therese A. M. J. van Amelsvoort
ASAnn Swillen
Ann Swillen
CVClaudia Vingerhoets
Claudia Vingerhoets
Marianne van den BreeMarianne van den Bree
Marianne van den Bree
22q11.2 Deletion Syndrome (22q11.2DS) is associated with high risk of psychiatric disorders and cognitive impairment. It remains unclear to what extent key cognitive skills are associated with psychopathology, and whether cognition is stable over time in 22q11.2DS. 236 children, adolescents and adults with 22q11.2DS and 106 typically developing controls were recruited from three sites across Europe. Measures of IQ, processing speed, sustained attention, spatial working memory and psychiatric assessments were completed. Cognitive performance in individuals was calculated relative to controls in different age groups (children (6–9 years), adolescents (10–17 years), adults (18+ years)). Individuals with 22q11.2DS exhibited cognitive impairment and higher rates of psychiatric disorders compared to typically developing controls. Presence of Autism Spectrum Disorder symptoms was associated with greater deficits in processing speed, sustained attention and working memory in adolescents but not children. Attention deficit hyperactivity disorder in children and adolescents and psychotic disorder in adulthood was associated with sustained attention impairment. Processing speed and working memory were more impaired in children and adults with 22q11.2DS respectively, whereas the deficit in sustained attention was present from childhood and remained static over developmental stages. Psychopathology was associated with cognitive profile of individuals with 22q11.2DS in an age-specific and domain-specific manner. Furthermore, magnitude of cognitive impairment differed by developmental stage in 22q11.2DS and the pattern differed by domain.

1 December 2015 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
AMA M Maillard
A M Maillard
LHL Hippolyte
L Hippolyte
BRB Rodriguez-Herreros
B Rodriguez-Herreros
SCS J R A Chawner
S J R A Chawner
DDD Dremmel
D Dremmel
SJS Jacquemont
S Jacquemont
The 600 kb BP4-BP5 copy number variants (CNVs) at the 16p11.2 locus have been associated with a range of neurodevelopmental conditions including autism spectrum disorders and schizophrenia. The number of genomic copies in this region is inversely correlated with body mass index (BMI): the deletion is associated with a highly penetrant form of obesity (present in 50% of carriers by the age of 7 years and in 70% of adults), and the duplication with being underweight. Mechanisms underlying this energy imbalance remain unknown. This study aims to investigate eating behavior, cognitive traits and their relationships with BMI in carriers of 16p11.2 CNVs. We assessed individuals carrying a 16p11.2 deletion or duplication and their intrafamilial controls using food-related behavior questionnaires and cognitive measures. We also compared these carriers with cohorts of individuals presenting with obesity, binge eating disorder or bulimia. Response to satiety is gene dosage-dependent in pediatric CNV carriers. Altered satiety response is present in young deletion carriers before the onset of obesity. It remains altered in adolescent carriers and correlates with obesity. Adult deletion carriers exhibit eating behavior similar to that seen in a cohort of obesity without eating disorders such as bulimia or binge eating. None of the cognitive measures are associated with eating behavior or BMI. These findings suggest that abnormal satiety response is a strong contributor to the energy imbalance in 16p11.2 CNV carriers, and, akin to other genetic forms of obesity, altered satiety responsiveness in children precedes the increase in BMI observed later in adolescence.